A New Era : FDA Approves Wegovy for Noncirrhotic MASH
Wegovy becomes the first GLP-1 receptor agonist approved by the US FDA for non-cirrhotic MASH, offering a new treatment option alongside diet and lifestyle changes.
A New Era : FDA Approves Wegovy for Noncirrhotic MASH Read Post »
